Synthetic risk transfers (SRTs) have been raising eyebrows lately. They were first introduced in Europe in the early 2000s as a niche form of capital optimization and have since become one of the most important tools in modern bank balance sheet management.[1]
Since 2016, banks have conducted SRTs referencing more than $1.1 trillion in underlying assetswith annual issuance worth tens of billions of dollars. As activity has increased and private credit funds have eagerly absorbed the contracts, regulators and financial journalists have become increasingly vocal about their concerns.
The question is whether this investigation is justified.
What are SRTs?
SRTs are a form of synthetic securitization, often called ‘on-balance-sheet securitization’, where a bank transfers some of the credit risk of a loan portfolio through a contract, typically a credit derivative or guarantee., without selling the loans completely or removing them from the balance sheet.
In Europe, where the market originated, the investor typically acquires the risk of mezzanine loans by selling (writing) a credit default swap (CDS) and, in the United States, through a credit-linked note (CLN). The primary sellers of protection are public and private credit funds, attracted by competitive returns, access to diversified, high-quality credit exposures and the ability to tailor risk through tranches. Banks pay for this protection because it allows them to transfer some of their lending risk to investors, which in turn lowers their regulatory capital requirements and frees up capital for new loans at a lower cost than raising equity.
The original bank retains the first loss tranche (junior).[2]. The investor, who has no specific knowledge of the pool’s underlying loans (only general details such as duration, ratings and sector), earns a fixed premium or coupon. If defaults occur in the portfolio, the bank absorbs the first loss, while the investor covers the losses up to the limit of the mezzanine tranche.
The bank maintains the customer relationship, loan management and interest income to maintain ‘skin in the game’, which is a regulatory requirement. But because the bank loses part of the portfolio risk, it is allowed to reduce the capital on the loans.
SRTs are typically designed for capital support and risk management. On the former, the Basel capital rules are widely regarded as excessively punitive on certain assets. For example, car loans require a disproportionate amount of capital, despite extremely low default rates. SRTs allow banks to reduce risk-weighted assets (RWAs) by 50% to 80% on many transactions. Furthermore, by transferring risk without shrinking their balance sheets, banks can reduce geographic, borrower or sector concentration risk.
Where SRTs are growing and why
European banks remain the most active issuers, accounting for roughly 60% to 70% of global issuance. The market has its roots in Europe as it is a bank-oriented credit market with a strict interpretation of capital regulations following the Global Financial Crisis (GFC). A clear regulatory framework and a deep investor base in Europe have also supported growth. Every SRT transaction is assessed by the European Central Bank/European Banking Authorityand recent regulatory rules have rewarded high-quality structures with more efficient capital handling.
In the United States it follows The Federal Reserve’s 2023 guidance By recognizing that direct CLN structures were eligible for capital support, banks quickly entered the market. The United States now represents almost 30% of global deal flow. In Asia, institutions in markets such as Australia and Singapore have experimented with SRT-like structures, often under different labels or pilot programs, although volumes are significantly smaller.
Born from overregulation, yet heavily scrutinized
Despite their benefits, SRTs remain subject to significant regulatory scrutiny. Regulators are most focused on rollover risk, investor concentration and back-leverage, all of which could become more apparent as issuance increases.
First, rollover risk arises because SRTs typically mature within three to five years, while the underlying loans often remain on the balance sheet for much longer. If market conditions deteriorate when an SRT comes up for renewal, banks may struggle to replace protection, leading to a sudden increase in risk-weighted assets and potential pressure to deleverage.
Secondly, this risk is increased by the concentration of investors: a relatively small group of private credit funds dominate the mezzanine market. Their outsized role means that the entire SRT ecosystem depends on the willingness of a handful of players to refinance. In a tense market, these funds could demand sharply higher spreads or withdraw altogether, leaving banks with limited alternatives.
Third, regulators are attuned to back-leverage. According to Basel III/IV and regional rules (e.g. the European Union Capital Requirements Regulation), a bank must prove that a material part of the portfolio has been transferred, that the transfer is real and that investors can be protected even under tense market conditions.
By requiring evidence of transfer of material risks and banks’ role in the game, the rules are intended to prevent regulatory arbitrage through circular transactions and ensure that SRTs strengthen rather than weaken the resilience of the financial system.
Finally, concerns remain about opacity. While SRTs are much more standardized and transparent than pre-2008 collateralized debt obligations, their bespoke nature and limited disclosure still leave some observers uncomfortable assessing the true distribution of risk.
Eye on the ball
For banks, SRTs have become a strategic lever to manage capital, limit credit exposure and keep lending volumes intact as the regulatory environment tightened following the financial crisis.
The public skepticism surrounding SRTs is, in my opinion, a result of PTSD from the financial crisis. The main difference this time is that moral hazard is significantly lower than in the pre-2008 period. Banks retain their exposure to first losses, investors retain real risks and the overall market remains relatively small.
On the contrary, the issuance of SRT is a response to overly conservative risk weights that have prompted banks to restrict lending in the years following the crisis. It is a rational approach to redistribute risk and free up capital for investment, especially in Europe, where banks are by far the dominant player. For institutional investors, SRTs offer potentially differentiated credit exposure and attractive returns.
[1] SRTs are also referred to as ‘significant risk transfers’. Most of it refers to meeting regulatory criteria (such as the Basel rules) to obtain capital relief (reducing the capital requirement) by proving that sufficient risk has actually been transferred, while synthetic emphasizes transferring risk through derivatives (such as CDS) rather than selling the asset itself (a cash securitization).
[2] In the US, the bank typically retains the first loss tranche and transfers the senior risk (only two tranches in the transaction).
#Synthetic #risk #transfers #talk #town #scary #CFA #Institute #Enterprising #Investor